Breakthrough drugs have made it possible for people to live with HIV longer than ever before, but more work must be done to actually cure the disease. One of the challenges researchers face involves fully eradicating the virus when it is latent in the body. A new report appearing in the December 2012 issue of the Journal of Leukocyte Biology suggests that a cancer drug, called JQ1, may be useful in purging latent HIV infection by activating the virus in the presence of potent therapy – essentially a dead end for the virus.
"This drug may be useful as adjunctive therapy in efforts to purge latent HIV reservoirs to eradicate infection," said Monty A. Montano, Ph.D., principal investigator from the Section of Infectious Diseases at Boston University Medical Campus, in Boston, Mass. "This drug functions synergistically with other HIV purging agents."
To make this discovery, scientists used cell lines that contained latent HIV, as well as cells from patients who were on potent antiretroviral therapy with no detectable virus in their blood. Researchers then added JQ1 to latently infected cells, at physiologic concentrations, and observed potent reactivation of latent HIV. The researchers also observed potent suppression of inflammatory genes in genome-wide expression studies using the same cells. JQ1 reactivation of latent HIV may make it vulnerable to current therapies.
"One thing that's been made clear by the decades of HIV research is that there is no magic bullet for curing this disease," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Rather, the progress that's been made has been a series of incremental steps that often build on other previously developed therapies. The hope is that the ability of JQ1 to make latent HIV 'visible' to other HIV drugs described in this report will be another cog in the gearwheel of an HIV cure."
Federation of American Societies for Experimental Biology: http://www.faseb.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
The Nikon Small World photomicrography competition was expanded to include video three years ago, and the result has been an incredible look into living things on the microscopic scale. This year's winning video is a three-dimensional look through a 10-day-old quail embryo growing inside its egg.
On a foggy night in 1888, the passenger steamer City of Chester was headed out of San Francisco Bay when disaster struck. The 202-foot boat was rammed by a much larger steamer, the Oceanic, coming into the bay from Asia. Sixteen people died in the accident, and the City of Chester quickly sank to the bottom. This multibeam sonar image from NOAA is the first look at the steamer in well over a century.
People who have lost their hearing will be injected with a harmless virus carrying a gene that should trigger the regrowth of their ears' sensory receptors
She lived to 115, but a study of Hendrikje van Andel-Schipper's blood hints at factors limiting lifespan
Most of us aren't as maleficent as the fairy in "Sleeping Beauty," but we're still apt to spite others, even at risk of harming ourselves. Psychologists are trying to figure out why.
PTSD treatments could soon extend beyond therapy
Areas where Czechoslovakia had three electrified fences now avoided by generation of deer who never encountered them
The mystery of a bizarre quacking sound often heard in the Southern Ocean has finally been solved, scientists report.
Why the connections between brain cells in depressed people are often shrivelled was a mystery – but a single protein could be to blame
The threat of mutually assured destruction, military or economic, promotes peace in many places. If war has ultimately forged a safer world, what's next?